Início › Câncer de Bexiga › Carolina do Norte › Durham
Ensaios clínicos de Câncer de Bexiga em Durham, NC
20 estudos para Câncer de Bexiga estão buscando participantes em locais em Durham e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Durham VA Medical Center, Durham
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecrutandoFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecrutandoFase 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- e mais 1
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecrutandoFase 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
RecrutandoEstudo observacional
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RecrutandoFase 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecrutandoEstudo observacional
- UNC- Chapel Hill, Chapel Hill · a 10 mi de distância
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RecrutandoFase 2
- University of North Carolina, Chapel Hill · a 10 mi de distância
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecrutandoFase 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · a 10 mi de distância
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
RecrutandoFase 2/3
- Research Site, Chapel Hill · a 10 mi de distância
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RecrutandoFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecrutandoFase 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · a 10 mi de distância
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
RecrutandoEstudo observacional
- University of North Carolina, Chapel Hill · a 10 mi de distância
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecrutandoFase 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi de distância
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · a 10 mi de distância
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Recrutando
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · a 10 mi de distância
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
RecrutandoEstudo observacional
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecrutandoFase 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi de distância
Ensaios de Câncer de Bexiga em outras cidades
- New York City, NY35 estudos
- Nashville, TN31 estudos
- Houston, TX31 estudos
- Dallas, TX27 estudos
- Boston, MA26 estudos
- Washington, DC26 estudos
- Los Angeles, CA24 estudos
- Baltimore, MD24 estudos
- St. Louis, MO22 estudos
- Philadelphia, PA21 estudos
- Seattle, WA21 estudos
- Edison, NJ21 estudos
Outros estudos em Durham
- Câncer de Mama63 estudos
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células39 estudos
- Mieloma Múltiplo37 estudos
- Câncer Metastático33 estudos
- Leucemia Mieloide Aguda33 estudos
- Câncer de Pulmão32 estudos
- Câncer de Próstata32 estudos
- Câncer Colorretal28 estudos
- Leucemia Linfocítica Crônica27 estudos
- Câncer de Ovário27 estudos
- Insuficiência Cardíaca26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.